Signalling Pathways 2017: Industry Sponsored Satellite Symposium

Thinking of attending ESMO Symposium on Signalling Pathways in Cancer 2017? Check the Industry Sponsored Satellite Symposium Programme

Friday, 17 March 2017 

DDR & PARPi for cancer treatments: Today and tomorrow 

18:30-19:30 

COR2ED (supported by an independent grant from AstraZeneca) 

Co-Chairs: Charlie Gourley, Edinburgh, UK and Mark O’Connor, Saffron Walden, UK 

Introduction, 18:30 

Charlie Gourley, Edinburgh, UK 

PARP inhibitors in ovarian cancer, 18:35 

Charlie Gourley, Edinburgh, UK 

PARP inhibitors beyond ovarian cancer, 18:50 

Judith Balmaña, Barcelona, Spain 

DDR beyond PARP inhibitors, 19:05 

Thomas Helleday, Stockholm, Sweden 

Conclusions, 19:20 

Charlie Gourley, Edinburgh, UK and Mark O’Connor, Saffron Walden, UK